Key facts
- This page summarizes Wendy Carruthers's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 10 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 21:03.
Wendy Carruthers - 16 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)
- Reporting relationship
- EVP, Human Resources
- Issuer ticker
- BSX
- Reported as of
- 16 Feb 2024
- Net transaction value
- -$179,689
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 21:03:46 UTC
- Prior SEC filing
- 16 Feb 2024
- Next SEC filing
- 26 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Thompson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Wendy Carruthers filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 16 Feb 2024.
- Current net transaction value: -$179,689.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,051
- Change %
- +3.5%
- Price
- $0.000000
- Shares after
- 60,905
- Date
- 16 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
BSX
transaction
Common Stock
Tax liability
- Transaction value
- $59,896
- Shares
- -910
- Change %
- -1.5%
- Price
- $65.82
- Shares after
- 59,995
- Date
- 16 Feb 2024
- Ownership
- Direct
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,250
- Change %
- +3.8%
- Price
- $0.000000
- Shares after
- 62,245
- Date
- 17 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
BSX
transaction
Common Stock
Tax liability
- Transaction value
- $65,688
- Shares
- -998
- Change %
- -1.6%
- Price
- $65.82
- Shares after
- 61,247
- Date
- 17 Feb 2024
- Ownership
- Direct
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,853
- Change %
- +3%
- Price
- $0.000000
- Shares after
- 63,100
- Date
- 18 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
BSX
transaction
Common Stock
Tax liability
- Transaction value
- $54,104
- Shares
- -822
- Change %
- -1.3%
- Price
- $65.82
- Shares after
- 62,278
- Date
- 18 Feb 2024
- Ownership
- Direct
BSX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -3,050
- Change %
- -4.9%
- Price
- $0.000000
- Shares after
- 59,228
- Date
- 20 Feb 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,051
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 4,102
- Date
- 16 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,051
- Exercise price
- Footnotes
- F1, F3
BSX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,250
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 2,250
- Date
- 17 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,250
- Exercise price
- Footnotes
- F1, F4
BSX
transaction
Derivative
Deferred Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,853
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,853
- Exercise price
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Footnote F2
Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
Footnote F3
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Footnote F4
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
Footnote F5
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.